Kura Oncology, Inc. KURA 深 滬

美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级

今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元

03-25 10:31

Mizuho Maintains Outperform on Kura Oncology, Lowers Price Target to $25

Mizuho analyst Mara Goldstein maintains Kura Oncology (NASDAQ:KURA) with a Outperform and lowers the price target from $30 to $25.

03-25 01:11

新浪财经ESG：Kura Oncology Inc MSCI（明晟）ESG评级调降至B

　　新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...

03-24 10:24

美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级

今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元

03-16 18:19

UBS Maintains Buy on Kura Oncology, Lowers Price Target to $15

UBS analyst David Dai maintains Kura Oncology (NASDAQ:KURA) with a Buy and lowers the price target from $16 to $15.

03-14 04:27

美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价

今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元

03-09 11:47

Kura Oncology (KURA) Receives a Hold from Guggenheim

In a report released yesterday, from Guggenheim maintained a Hold rating on Kur...

03-07 21:46

Wedbush Maintains Outperform on Kura Oncology, Lowers Price Target to $36

Wedbush analyst Robert Driscoll maintains Kura Oncology (NASDAQ:KURA) with a Outperform and lowers the price target from $38 to $36.

03-06 21:49

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) March 6 (Reuters) - Kura Oncology Inc KURA.O : KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNX3yZRDN Further company coverage: KURA.O (( Reuters.Briefs@thomsonreuters.

03-06 20:30

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03-06 12:30